PT - JOURNAL ARTICLE AU - Babak Jamshidi AU - Amir Talaei-Khoei AU - Shahriar Jamshidi Zargaran AU - Mansour Rezaei TI - Forecasting new daily confirmed cases infected by COVID-19 in Italy from April 9<sup>th</sup> to May 18<sup>th</sup> 2020 AID - 10.1101/2020.10.30.20223222 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.30.20223222 4099 - http://medrxiv.org/content/early/2020/11/04/2020.10.30.20223222.short 4100 - http://medrxiv.org/content/early/2020/11/04/2020.10.30.20223222.full AB - We aim at forecasting the outbreak of COVID-19 in Italy by using a two-part time series to model the daily relative increments. Our model is based on the data observed from 22 February to 8 April 2020 and its objective is forecasting 40 days from 9 April to 18 May 2020. All the calculations, simulations, and results in the present paper have been done in MatLab R2015b. The average curve and 80% upper and lower bounds are calculated based on 100 simulations of the fitted models. According to our model, it is expected that by May 18th, 2020, the relative increment (RI) falls to the interval of 0.31% to 1.24% (average equal to 0.78%). During the last three days of the studied period, the RI belonged to the interval 2.5% to 3%. Accordingly, It is expected that the new daily confirmed cases face a decreasing to around 1900 on average. Finally, our prediction establishes that the cumulative number of confirmed cases reaches 237635 (with 80% confidence interval equal to [226340 248417] by May 18th, 2020.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/AAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yeshttps://www.worldometers.info/coronavirus/coronavirus-cases/